Highland Capital Management (Texas)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $514K | Buy |
6,000
+3,000
| +100% | +$257K | 0.03% | 219 |
|
|
2019
Q1 | $266K | Sell |
3,000
-1,500
| -33% | -$133K | 0.02% | 250 |
|
|
2018
Q4 | $383K | Buy |
4,500
+2,050
| +84% | +$174K | 0.03% | 211 |
|
|
2018
Q3 | $238K | Hold |
2,450
| – | – | 0.01% | 282 |
|
|
2018
Q2 | $231K | Sell |
2,450
-13,960
| -85% | -$1.32M | 0.01% | 285 |
|
|
2018
Q1 | $1.33M | Buy |
16,410
+13,960
| +570% | +$1.13M | 0.07% | 160 |
|
|
2017
Q4 | $218K | Hold |
2,450
| – | – | 0.01% | 263 |
|
|
2017
Q3 | $228K | Hold |
2,450
| – | – | 0.01% | 262 |
|
|
2017
Q2 | $223K | Hold |
2,450
| – | – | 0.01% | 272 |
|
|
2017
Q1 | $215K | Sell |
2,450
-17,839
| -88% | -$1.57M | 0.01% | 254 |
|
|
2016
Q4 | $1.68M | Buy |
20,289
+17,839
| +728% | +$1.48M | 0.08% | 144 |
|
|
2016
Q3 | $227K | Sell |
2,450
-40,000
| -94% | -$3.71M | 0.01% | 262 |
|
|
2016
Q2 | $3.3M | Sell |
42,450
-73,521
| -63% | -$5.72M | 0.14% | 116 |
|
|
2016
Q1 | $9.57M | Buy |
+115,971
| New | +$9.57M | 0.42% | 59 |
|